Short term incubation of ovarian cancer cells with chemotherapeutic regimens (e.g. doxorubicin, cisplatin and paclitaxel) at their clinical concentrations [9] increases MDR1 expression levels. This evidence concerns the gene ABCB1 and ovarian cancer.